ArticleCureus2026
Psychiatric-Predominant Wernicke Encephalopathy With Normal Blood Thiamine Levels: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wernicke encephalopathy (WE), caused by thiamine deficiency in patients with chronic alcohol use, may progress to Korsakoff syndrome if untreated. Diagnosis is challenging and often missed because the classic triad can be incomplete and blood thiamine levels can be normal. A 56-year-old woman with 40-60 g of pure alcohol consumption daily since her 20s and a previous psychiatric hospitalization for alcohol dependence at the age of 50 years developed hallucinations, delusions, agitation, and cognitive decline. One month later, she fractured her left femoral neck at home, for which she underwent hemiarthroplasty at a general hospital. Although no clear alcohol withdrawal symptoms were observed, the patient was unable to engage in meaningful conversations and was diagnosed with alcohol-related dementia. Antipsychotic treatment was ineffective, and she was transferred to our hospital. Upon admission, her Hasegawa Dementia Scale-Revised (HDS-R) score was 1. Neurological examination, brain computed tomography (CT), and laboratory tests, including blood thiamine levels, appeared normal. Based on the patient's clinical course, WE was suspected. High-dose intravenous thiamine (400 mg/day) was administered for five days, followed by oral thiamine. Her psychiatric symptoms and cognitive function rapidly improved, and the HDS-R score increased to 27 by day 17. The patient was diagnosed with WE. WE diagnosis can be difficult, particularly in patients with alcohol use disorder and atypical presentations. High-dose intravenous thiamine is safe and may serve as an intervention with diagnostic value when WE cannot be excluded.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.